Pituitary society guidance: pituitary disease management and patient care recommendations during the COVID-19 pandemic-an international perspective

被引：45

作者：

Fleseriu, Maria ^{[1
]}

Buchfelder, Michael ^{[2
]}

Cetas, Justin S. ^{[1
,3
]}

Fazeli, Pouneh K. ^{[4
]}

Mallea-Gil, Susana M. ^{[5
]}

Gurnell, Mark ^{[6
,7
]}

McCormack, Ann ^{[8
,9
]}

Pineyro, Maria M. ^{[10
]}

Syro, Luis V. ^{[11
]}

Tritos, Nicholas A. ^{[12
,13
,14
]}

Marcus, Hani J. ^{[15
]}

机构：

[1] Oregon Hlth & Sci Univ, Pituitary Ctr, Mail Code CH8N,3303 South Bond Ave, Portland, OR 97239 USA

[2] Univ Hosp Erlangen, Dept Neurosurg, Erlangen, Germany

[3] Vet Affairs Med Ctr, Portland, OR USA

[4] Univ Pittsburgh, Div Endocrinol & Metab, Neuroendocrinol Unit, Pittsburgh, PA USA

[5] Hosp Mil Cent, Div Endocrinol, Buenos Aires, DF, Argentina

[6] Univ Cambridge, Addenbrookes Hosp, Cambridge, England

[7] Wellcome Trust MRC Inst Metab Sci, NIHR Cambridge Biomed Res Ctr, Cambridge, England

[8] St Vincents Hosp, Dept Endocrinol, Sydney, NSW, Australia

[9] Garvan Inst Med Res, Sydney, NSW, Australia

[10] Univ Republica, Fac Med, Hosp Clin, Clin Endocrinol & Metab, Montevideo, Uruguay

[11] Hosp Pablo Tobon Uribe & Clin Medellin, Dept Neurosurg, Grp Quironsalud, Medellin, Colombia

[12] Massachusetts Gen Hosp, Neuroendocrine Unit, Boston, MA 02114 USA

[13] Massachusetts Gen Hosp, Neuroendocrine & Pituitary Tumor Clin Ctr, Boston, MA 02114 USA

[14] Harvard Med Sch, Boston, MA 02115 USA

[15] Natl Hosp Neurol & Neurosurg, London, England

来源：

PITUITARY | 2020年 / 23卷 / 04期

关键词：

SARS-CoV-2; COVID-19; Pituitary disease and surgery; Cushing's disease; Acromegaly; Prolactinomas; MORTALITY;

D O I：

10.1007/s11102-020-01059-7

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the viral strain that has caused the coronavirus disease 2019 (COVID-19) pandemic, has presented healthcare systems around the world with an unprecedented challenge. In locations with significant rates of viral transmission, social distancing measures and enforced 'lockdowns' are the new 'norm' as governments try to prevent healthcare services from being overwhelmed. However, with these measures have come important challenges for the delivery of existing services for other diseases and conditions. The clinical care of patients with pituitary disorders typically involves a multidisciplinary team, working in concert to deliver timely, often complex, disease investigation and management, including pituitary surgery. COVID-19 has brought about major disruption to such services, limiting access to care and opportunities for testing (both laboratory and radiological), and dramatically reducing the ability to safely undertake transsphenoidal surgery. In the absence of clinical trials to guide management of patients with pituitary disease during the COVID-19 pandemic, herein the Professional Education Committee of the Pituitary Society proposes guidance for continued safe management and care of this population.

引用

页码：327 / 337

页数：11